"Clinical Characteristics, Comorbidities and Outcome of Critically Sick Patients With COVID-19 Pneumonia Admitted in Intensive Care Unit of a Tertiary Care Hospital in Lahore, Pakistan": A Retrospective Cohort Study
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- COVID-19 Pneumonia
- Sponsor
- FMH College of Medicine and Dentistry
- Enrollment
- 133
- Locations
- 1
- Primary Endpoint
- Mortality
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
COVID-19, caused by severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), is a multisystem disease which primarily involves the respiratory tract. The first case of COVID-19 was identified in late 2019 in the province of Wuhan, China which was followed by the rapid spread of the disease globally, becoming a present-day pandemic.
Objectives: The aim of this study was to describe the clinical characteristics, comorbidities and outcome of the critically sick patients with COVID-19 pneumonia admitted in ICU of a tertiary care hospital in Lahore.
Detailed Description
Objectives: The aim of this study was to describe the clinical characteristics, comorbidities and outcome of the critically sick patients with COVID-19 pneumonia admitted in ICU of a tertiary care hospital in Lahore. Material \& Methods: Study design: Retrospective study. Study Settings: Study was conducted in Fatima Memorial Hospital, Lahore. Study Duration: Study was conducted on Covid-19 patients who were admitted from March 2021 to August 2021.
Investigators
Aijaz Zeeshan Khan Chachar
Consultant Physician (Senior Registrar)
FMH College of Medicine and Dentistry
Eligibility Criteria
Inclusion Criteria
- •Critically sick patients with COVID-19 Pneumonia
- •All admitted ICU patients with a diagnosis of COVID-19 pneumonia
- •Patients having positive reverse transcriptase PCR for COVID-19
- •Patients with High-resolution computed tomography (HRCT) chest findings suggestive of COVID-related lung injury
- •All patients above 16 years of age with both genders( males and females)
Exclusion Criteria
- •All patients with PCR negative with mild symptoms
- •Patients with No signs of COVID-19 pneumonia on HRCT chest
Outcomes
Primary Outcomes
Mortality
Time Frame: 6 months
The primary endpoint of the study will be to assess the ICU mortality (in percentages% and Numbers) of critically sick patients with COVID-19 pneumonia admitted to the intensive care unit
Secondary Outcomes
- Comorbidities(6 months)